Contact Force Sensing Use in Atrial Fibrillation Ablation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01630330 |
Recruitment Status : Unknown
Verified June 2012 by Royal Brompton & Harefield NHS Foundation Trust.
Recruitment status was: Recruiting
First Posted : June 28, 2012
Last Update Posted : June 28, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Atrial Fibrillation | Procedure: Ablation | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 40 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Investigator) |
Primary Purpose: | Treatment |
Official Title: | The Role of Contact Force Sensing in Electrical Pulmonary Vein Isolation When Conducting Atrial Fibrillation Ablation |
Study Start Date : | May 2012 |
Estimated Primary Completion Date : | December 2013 |
Estimated Study Completion Date : | December 2013 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Contact Force Known
Ablation with contact force data known
|
Procedure: Ablation
Atrial Fibrillation Ablation with SmartTouch catheter |
Experimental: Contact Force Not Known
Contact Force data unavailable during ablation
|
Procedure: Ablation
Atrial Fibrillation Ablation with SmartTouch catheter |
- Rate of Acute Pulmonary Vein Reconnection [ Time Frame: 1 hour post procedure ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with symptomatic AF
Exclusion Criteria:
- Recent CVA
- Contraindication to warfarin therapy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01630330
Contact: Shouvik Haldar, MRCP | 0207 351 8121 ext 8742 | s.haldar@rbht.nhs.uk |
United Kingdom | |
Royal Brompton & Harefield Hospital NHS Foundation Trust | Recruiting |
London, United Kingdom, SW3 6NP | |
Principal Investigator: Tom Wong, MD, FRCP |
Responsible Party: | Royal Brompton & Harefield NHS Foundation Trust |
ClinicalTrials.gov Identifier: | NCT01630330 |
Other Study ID Numbers: |
2012CI002B |
First Posted: | June 28, 2012 Key Record Dates |
Last Update Posted: | June 28, 2012 |
Last Verified: | June 2012 |
Atrial Fibrillation Arrhythmias, Cardiac Heart Diseases Cardiovascular Diseases Pathologic Processes |